WO2015190706A1

WO2015190706A1 - Diabetes measuring device and operation method thereof

Info

Publication number: WO2015190706A1
Application number: PCT/KR2015/004627
Authority: WO
Inventors: 최우진
Original assignee: 최우진
Priority date: 2014-06-10
Filing date: 2015-05-08
Publication date: 2015-12-17
Also published as: KR20150141381A

Abstract

The present invention relates to: a diabetes measuring device which installs a diabetes sensor in a nasolacrimal duct of a diabetic patient, thereby checking diabetes; and an operation method thereof. An insertion tube is inserted and installed in a nasolacrimal duct to thereby transfer tears collected in the nasolacrimal duct; a diabetes sensor is inserted and installed in the insertion tube to thereby receive tears transferred through the insertion tube, check diabetes and measure the blood sugar; a wireless transmitter generates the blood sugar measured by the diabetes sensor as a wireless blood sugar information signal for transmitting to the outside, and transmits the same; and a self-supplied power supplier converts power to the power required by the diabetes sensor and the wireless transmitter and supplies the same.

Description

[Revision 29.07.2015 by Rule 26] Diabetes measuring device and its operation method

The present invention relates to a diabetic measuring apparatus and its operation method, and more particularly to a diabetic measuring apparatus and its operation method to install a diabetes sensor in the nasolacrimal duct of a diabetic patient to perform a diabetic check.

Diabetes mellitus is a serious disease that usually results in an increase in blood glucose due to abnormalities in the production or use of insulin and accompanying various acute and chronic complications. According to the 2005 National Diabetes Fact Sheet (NDFS) in the United States, more than 20 million people, or 9.6 percent of the population over 20 years of age, have diabetes and 50 million pre-diabetes patients at high risk. In 2002, $ 132 billion was spent on direct and indirect medical expenses related to diabetes. Also in Korea, according to the National Health and Nutrition Survey conducted by the Centers for Disease Control and Prevention in 2005, 9.0% of men over the age of 30 and 7.2% of women were diagnosed with diabetes, and the Korean Diabetes Association published ' According to the 2007 Korean Diabetes Research Report, the prevalence of diabetes is about 8%, 10% of new patients are generated each year, and diabetes-related medical expenses will account for about 3 trillion won, about 20% of health insurance costs. Given the recent rapid growth in the number of diabetics currently estimated at 4-5 million, it could reach 10 million in 10-20 years.

The longer the duration of diabetes is accompanied by a variety of systemic complications, including cardiovascular disease, diabetes mellitus, diabetic neuropathy, diabetic retinopathy. Diabetic Retinopathy (DR) occurs in patients with diabetes more than 60% within 10 years of diabetic diagnosis and in 90% or more within 20 years. Diabetic retinopathy is a micro-angiopathy of diabetes, characterized by permeability changes in retinal vessels, vascular obstruction, ischemia, neovascularization, and thus fibrovascular proliferation. to be.

Korean Patent Registration No. 10-1391506 (registered on April 25, 2014) describes a marker for diagnosing diabetic retinopathy and its use, and includes an agent for measuring mRNA or protein level of Alpha-1 acid glycoprotein (AGP) gene. As a composition for diagnosing non-proliferative diabetic retinopathy, APOC1 (Apolipoprotein C1), APOB100 (Apolipoprotein B100), APOC3 (Apolipoprotein C3), VTN (Vitronectin), PLG (Plasminogen), HRP (Histidine-rich protein), AFM (Afamin) And an agent for further measuring mRNA or protein levels of at least one gene selected from the group consisting of ceruloplasmin (CP), complement factor B (CFB), and pigment epithelium derived factor (PEDF). According to the disclosed technology, by providing a marker for diagnosing diabetic retinopathy, by measuring and comparing the expression level of the gene or its protein with increased or decreased expression in diabetic retinopathy, the early diagnosis and degree of disease of diabetic retinopathy It can be significantly predicted or identified, and also enables the non-invasive diagnosis can be a simple and effective early diagnosis of diabetic retinopathy by blood, urine test, and the like.

Korean Patent Laid-Open Publication No. 10-2002-0066792 (published Aug. 21, 2002) discloses immunochromatography that can be used to diagnose diabetes by quantitatively or semi-quantitatively confirming the sensitization in the blood of glycated hemoglobin, one of the diabetic labeling substances. A quick diagnosis kit and analysis method for diabetes using graphigraphy is described. According to the disclosed technique, in an immunochromatography technique using an antigen antibody, the antibody is immobilized on the surface of the nitrocellulose membrane to be set as a signal detection region, and the buffer pad, the gold conjugate pad, the sample pad, the nitrocellulose pad, and the hygroscopic pad in that order. Quantitative analysis by spectroscopy is performed in an analysis kit in which portions are overlapped, and semiquantitative analysis using color balance is performed.

In the prior art as described above, a diagnostic marker or a diagnostic kit is used to measure diabetes, but it is highly accurate to measure diabetes by blood, and blood is collected and checked at all hospitals. Because there was no choice but to check, there was an inconvenience caused by blood collection, and the pain associated with blood collection also caused problems for diabetics and the diabetic measurement management for diabetics was not performed properly. there was.

On the other hand, in the prior art by developing a non-invasive blood sugar management product through a smart contact lens to check the diabetes by planting a sensor in the body of the diabetic patient, side effects such as dry eye and foreign body when the wear is prolonged There is a problem that occurs. In addition, the sensor planted in the body of the diabetic patient has a problem that gives the diabetic patient the pain that must be stabbed once a month.

The technical problem to be achieved by the present invention is to solve the inconveniences or problems as described above, and provides a diabetic measuring device and its operation method to perform a diabetic check by installing a diabetes sensor in the nasolacrimal duct of a diabetic patient.

In order to solve this problem, according to one feature of the present invention, the insertion tube is inserted into the nasolacrimal duct, and delivers the tears collected in the nasolacrimal duct; A diabetic sensor inserted into the insertion tube to check a diabetes by receiving tears delivered through the insertion tube and measuring blood glucose; A wireless transmitter for generating and transmitting a blood glucose information signal for transmitting blood glucose measured by the diabetes sensor to the outside; And it provides a diabetes measuring device comprising a self-power supply for converting and supplying power to the diabetes sensor and the wireless transmitter.

In one embodiment, the insertion tube is cylindrical, characterized in that the tube made of silicon material is inserted into the nasolacrimal duct.

In one embodiment, the diabetes sensor has a width of 0.5 ~ 1.5mm and a length of 1 ~ 4mm, it is characterized in that it is replaced once every preset replacement period.

In one embodiment, the diabetic sensor is attached along the cylindrical inner surface of the insertion tube to the inside of the insertion tube in a cylindrical shape so that tears pass through the inner surface, or ?? Put the date in the form characterized in that the tears pass on both sides.

In one embodiment, the wireless transmitter is connected to the diabetic sensor in the form of a thin film, characterized in that it is fixed to the inner surface or the outer surface or the sinus of the insertion tube.

In one embodiment, the self-power supply is connected to the diabetes sensor and the wireless transmitter, characterized in that the battery of the thin film form fixed to the inner surface or the outer surface or the sinus of the insertion tube.

In one embodiment, the self-power supply is characterized in that the ultra-high efficiency nano power generation device for converting small micro-vibration of the nanometer level into electrical energy.

In one embodiment, the diabetic measuring device, characterized in that it further comprises an external display device for receiving a wireless blood glucose information signal from the wireless transmitter for displaying the measured blood glucose.

In an embodiment, the external display device may include: a wireless receiver configured to receive a wireless blood sugar information signal transmitted from the wireless transmitter and convert the wireless blood sugar information signal into a measured blood sugar; A display unit which displays the measured blood sugar converted by the wireless receiver on a screen; And a power supply unit receiving external commercial power or power from a battery or a rechargeable battery, converting and supplying the power to the wireless receiver and the display.

According to another feature of the invention, the insertion tube inserted into the nasolacrimal duct to deliver the tears gathered into the nasolacrimal duct; A self-power supply converts and supplies power to a diabetes sensor and a wireless transmitter; A diabetic sensor inserted into the insertion tube to receive the tear and check diabetes to measure blood glucose; And a wireless transmitter generating and transmitting a blood glucose information signal for transmitting blood glucose measured by the diabetes sensor to the outside.

In one embodiment, the operation method of the diabetic measuring device, the inserting device using a probe or endoscope to insert the insertion tube which is a tube of silicon material in the nasolacrimal duct; Inserting, by the insertion apparatus, the diabetes sensor into the insertion tube using an endoscope; When the diabetic sensor is inserted and installed, the inserting device using an endoscope to securely install a wireless transmitter connected to the diabetic sensor to an inner surface, an outer surface, or a sinus of the insertion tube; And installing and inserting the self-power supply in a state connected to the diabetic sensor and the wireless transmitter to the inner surface or the outer surface or the sinus of the insertion tube by using the endoscope. It further comprises.

In one embodiment, the operation method of the diabetic measuring device, the inserting device is installed by inserting the diabetic sensor already installed in the insertion tube, which is a tube made of silicone using a probe or endoscope directly into the nasolacrimal duct; When the diabetic sensor is inserted and installed, the inserting device using an endoscope to securely install a wireless transmitter connected to the diabetic sensor to an inner surface, an outer surface, or a sinus of the insertion tube; And installing and inserting the self-power supply in a state connected to the diabetic sensor and the wireless transmitter to the inner surface or the outer surface or the sinus of the insertion tube by using the endoscope. It further comprises.

In one embodiment, the step of inserting the diabetic sensor, the inserting device is installed along the cylindrical inner surface of the insertion tube in a cylindrical shape so that tears pass through the inner surface, or the insertion tube Inside the ?? Put the date in the form characterized in that the tear is installed on both sides pass.

In one embodiment, the step of inserting the diabetic sensor, the insertion device is pulled out of the diabetic sensor inserted into the insertion tube with a forceps while looking into the endoscope once every predetermined replacement period, the insertion tube using the endoscope It further comprises the step of replacing with a new diabetes sensor.

In one embodiment, the operation method of the diabetes measuring device, characterized in that the external display device further comprises the step of receiving and receiving the wireless blood glucose information signal converted to the measured blood sugar to display.

According to the present invention, by installing a diabetic sensor in the nasolacrimal duct of a diabetic patient to perform a diabetic check, the diabetic sensor can be installed in the nasolacrimal duct with a high density of tears through a simple non-invasive procedure, thereby easily checking blood glucose. It is very easy and convenient to manage the diabetic measurement for the diabetic patient, and it can greatly increase the accuracy of the diabetic measurement. Also, it is not necessary to collect the blood of the diabetic patient, thereby eliminating the inconvenience and pain caused by the blood collection. Non-invasive procedures for diabetics have the effect of reducing discomfort and rejection.

1 is a diagram illustrating a diabetic measuring apparatus according to an embodiment of the present invention.

2 is a view for explaining the installation of the insertion tube and diabetes sensor in FIG.

3 is a view for explaining the installation procedure of the insertion tube in FIG.

4 is a flowchart illustrating a method of operating a diabetic measuring apparatus according to an embodiment of the present invention.

Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art may easily implement the present invention. However, since the description of the present invention is only an embodiment for structural or functional description, the scope of the present invention should not be construed as being limited by the embodiments described in the text. That is, the embodiments may be variously modified and may have various forms, and thus, the scope of the present invention should be understood to include equivalents for realizing the technical idea. In addition, the objects or effects presented in the present invention does not mean that a specific embodiment should include all or only such effects, the scope of the present invention should not be understood as being limited thereby.

On the other hand, the meaning of the terms described in the present invention will be understood as follows.

Terms such as "first" and "second" are intended to distinguish one component from another component, and the scope of rights should not be limited by these terms. For example, the first component may be named a second component, and similarly, the second component may also be named a first component.

When a component is referred to as being "connected" to another component, it should be understood that there may be other components in between, although it may be directly connected to the other component. On the other hand, when a component is said to be "directly connected" to another component, it should be understood that there is no other component in between. On the other hand, other expressions describing the relationship between the components, such as "between" and "immediately between" or "neighboring to" and "directly neighboring to", should be interpreted as well.

Singular expressions should be understood to include plural expressions unless the context clearly indicates otherwise, and terms such as "include" or "have" refer to features, numbers, steps, operations, components, parts, or parts thereof described. It is to be understood that the combination is intended to be present and does not exclude in advance the possibility of the presence or addition of one or more other features or numbers, steps, operations, components, parts or combinations thereof.

All terms used herein have the same meaning as commonly understood by one of ordinary skill in the art unless otherwise defined. Generally, the terms defined in the dictionary used are to be interpreted as being consistent with the meanings in the context of the related art, and should not be interpreted as having ideal or excessively formal meanings unless clearly defined in the present invention.

Now, a diabetic measuring apparatus and its operating method according to an embodiment of the present invention will be described in detail with reference to the drawings.

1 is a view illustrating a diabetic measuring apparatus according to an embodiment of the present invention, Figure 2 is a view illustrating the installation of the insertion tube and the diabetes sensor in Figure 1, Figure 3 is an installation of the insertion tube in Figure 1 It is a figure explaining a procedure.

1 to 3, the diabetic measuring apparatus 100 includes an insertion tube 110, a diabetes sensor 120, a wireless transmitter 130, and a self-power supply 140.

Insertion tube 110 is inserted into the nasolacrimal duct, which is a tube leading from the eyes of the diabetic to the nostrils, and delivers the tears collected in the nasolacrimal duct to the diabetic sensor 120.

In one embodiment, the insertion tube 110 is a tube made of silicon, similar to a procedure for inserting a silicon tube through a nasal tube obstruction, and as shown in FIG. 2, inserted into the nasal tube in a cylindrical shape. Non-invasive procedures can reduce discomfort and rejection in diabetics.

In one embodiment, the insertion tube 110, as shown in Figure 3, may be inserted into the nasolacrimal duct by nasal tube stenting or fistula balloon dilation through a probe (Probe) or endoscope.

The diabetic sensor 120 is replaced once per predetermined replacement period and inserted into the insertion tube 110 to be driven by receiving power supplied from the self-power supply 140 and transmitted through the insertion tube 110. The tear is applied to check the diabetes to measure the blood sugar, and delivers the measured blood sugar to the wireless transmitter (130).

In one embodiment, the diabetic sensor 120, the width of the nasolacrimal duct is more than 2mm and the length is about 1.5cm, the width of 0.5 ~ 1.5mm and the length of 1 ~ 4mm (preferably, 1.13mm in width and 2.27mm in length) It can have an internal and external), it is inserted into the insertion tube 110 is installed once per month or once every two months while performing a diabetic check can be measured easily blood sugar. Here, the nasolacrimal duct is a part where the tears are collected, and thus the density of tears is higher than that of other eyes, thereby increasing the diabetic measurement accuracy of the diabetic sensor 120 installed in the nasolacrimal tube.

In one embodiment, the diabetic sensor 120 can be installed by pushing into the insertion tube 110 installed in the nasolacrimal duct using a probe or endoscope, and can be pulled out with a forceps while looking at the endoscope later to be removed. At this time, the diabetic sensor 120, as shown in Figure 2, as a sensor formed of nano-porous platinum that can be used in a living environment, the elongated tip can be mounted in the nasolacrimal duct into the insertion tube 110, the electrode A wide part of the shape may be connected to the self-power supply 140 through a flip-lock connector and mounted on the sinus.

In one embodiment, the diabetic sensor 120, the cylindrical through the cylindrical inner surface of the insertion tube 110 to the inside of the insertion tube 110 to pass the tears to the inner surface, or inside the insertion tube (110) On ?? You can also put a date in the form so that the tears pass on both sides. In addition, the diabetic sensor 120 may be fitted into the inner surface of the insertion tube 110 in the case of a cylindrical shape.

The wireless transmitter 130 is a proximity wireless communication module such as an RF communication module, an NFC communication module, etc., and is driven by receiving power supplied from the self-power supply 140, and externally measures the measured blood sugar transmitted from the diabetes sensor 120. For example, the wireless glucose information signal is converted into a wireless signal (ie, a wireless blood sugar information signal) for transmission to the external display device 150 and transmitted to the outside.

In one embodiment, the wireless transmitter 130, in the form of a thin film, may be connected to the diabetes sensor 120 may be fixed to the inner surface or the outer surface of the insertion tube (110).

In one embodiment, the wireless transmitter 130 is connected to the diabetic sensor 120 to the sinuses through the hole to check the hole entering the sinus (Maxillary Sinus Ostium) in the nose using an endoscope placed into the nose to be installed. It may also be removed simply by an endoscope through the nose if necessary.

The self-power supply 140 self-generates electrical energy (that is, power) to generate power of the self-generated components of the diabetes measuring apparatus 100 (that is, the diabetes sensor 120 and the wireless transmitter 130). It converts the power required for the supply of the converted power to the diabetes sensor 120 and the wireless transmitter 130.

In one embodiment, the self-power supply 140 is a thin film type battery, connected to the diabetes sensor 120 and the wireless transmitter 130 may be fixed to the inner surface or the outer surface of the insertion tube 110. .

In one embodiment, the self-power supply 140 is connected to the diabetic sensor 120 and the wireless transmitter 130 to the sinuses through the hole to check the hole entering the sinus in the nose using the endoscope put into the nose It may be installed or simply removed by an endoscope through the nose if necessary.

In one embodiment, the self-power supply 140 is a self-generator by vibrating using the nano-device made by coupling the micro-generator to the nanoelectronic system circuit through the nano-device manufacturing process (that is, small fine vibration of several nanometers level) Ultra-high-efficiency nano-power generation device that converts the energy into electrical energy.The nanoscale polymer ribbon is laid down over a few micrometer-thick zinc oxide rod, and the nanoscale electrode is deposited thereon to deposit the electrode from the zinc oxide rod. It can be formed by electrically connecting with an external circuit formed up to this substrate. In addition, the self-power supply 140 covers a 100 nanometer-thick polymer film on the substrate on which the zinc oxide microrods are placed, and then applies a strong electron beam to generate a polymer bond to localize the nanoribbon that is connected from the top of the microrods to the underlying substrate. And the formed nanoribbons form a strong connection between the microrods and the circuits on the substrate without being affected by the physical and chemical processes exposed during the device fabrication process, like ropes hanging from the building to the ground. A few tens of nanometers of metal can be deposited over the structure to stabilize the electrical connection between the zinc oxide rods and the circuitry below the substrate.

Diabetic measuring device 100 having the configuration as described above, by installing the diabetic sensor 120 in the nasolacrimal duct of the diabetic patient to perform the diabetic check, denseness of the diabetic sensor 120 through a simple non-invasive procedure Because it can be installed in the high nasolacrimal duct, it is easy to check the blood sugar, and it is very easy and convenient to manage the diabetic measurement for the diabetic patient, and it is possible to increase the accuracy of the diabetic measurement very much, and also it is not necessary to collect the blood of the diabetic patient. In addition, it is possible to eliminate the discomfort and pain associated with blood collection, and to reduce the discomfort and rejection by non-invasive procedures for diabetics.

When the diabetic measuring device 100 having the above-described configuration is installed in the nasolacrimal duct or sinus, when the volume of the wireless transmitter 130 or the self-power supply 140 is larger than the volume of the diabetic sensor 120, Without inserting into the nasolacrimal duct to start, the nasal tube ending in the nose through the endoscope can be put into the diabetic sensor 120 installed in the insertion tube 110 toward the eye, the wireless transmitter 130 or connected to the other end The self-power supply 140 may be inserted into the sinus.

The diabetes measuring apparatus 100 having the above-described configuration may further include an external display device 150 including a wireless receiver 151, a display 152, and a power supply 153. Here, the external display device 150 may be a terminal capable of close wireless communication such as a smart phone, a notebook, and the like. In addition, such a terminal may receive an wireless blood glucose information signal from the wireless transmitter 130 and install an app or a program for displaying the measured blood glucose.

The wireless receiver 151 is a proximity wireless communication module such as an RF communication module, an NFC communication module, and the like, and is driven by receiving power supplied from the power supply unit 153, and transmits a wireless blood sugar information signal transmitted from the wireless transmitter 130. The received blood sugar is converted into measurement blood sugar and then transferred to the display unit 152.

The display unit 152 is a screen display means such as an LCD and the like, is driven by receiving power supplied from the power supply unit 153, and displays the measured blood sugar transmitted from the wireless receiver 151 on the screen.

The power supply unit 153 is supplied with external commercial power or a battery (or a rechargeable battery) to each component of the external display device 150 (that is, the wireless receiver 151 and the display unit 152). The power is converted into necessary power and the converted power is supplied to the wireless receiver 151 and the display 152.

Referring to FIG. 4, first, an insertion device such as a robot arm inserts an insertion tube 110, which is a tube made of silicon, into a nasolacrimal duct that is a tube leading from the eyes of a diabetic patient to a nostril (S401).

In the above-described step S401, the insertion device such as a robotic arm is inserted into the insertion tube 110 into the nasolacrimal duct that is 2 mm or more in width and 1.5 cm in length by nasolacrimal stenting or fistula balloon dilation using a probe or endoscope. Can be. In other words, similar to a procedure in which a silicone tube is inserted and drilled when there is a nasolacrimal duct obstruction, an insertion device such as a robot arm can insert a cylindrical insertion tube 110 into the nasolacrimal duct, thereby providing a non-invasive procedure to a diabetic patient. It can reduce discomfort and rejection.

After inserting and installing the insertion tube 110 in the above-described step S401, the diabetic sensor 120 is inserted into the insertion tube 110, or already in the insertion tube 110 directly in the nasolacrimal duct without performing the above-described step S401. Inserted diabetic sensor 120 is installed (S402).

In the above-described step S402, an insertion device such as a robotic arm is 0.5 to 1.5 mm wide and 1 to 4 mm long (preferably 1.13 mm wide and into the insertion tube 110 installed in the nasolacrimal duct using a probe or endoscope). 2.27mm length) can be installed by pushing the diabetic sensor 120.

In the above-described step S402, an insertion device such as a robot arm is attached to the inner surface of the insertion tube 110 by the cylindrical diabetic sensor 120 along the cylindrical inner surface of the insertion tube 110 so that the tears pass to the inner surface. And also, inserting device such as robot arm is inserted into the insertion tube (110) ?? By putting the diabetic sensor 120 of the date in the form of a date may be installed so that the tears pass on both sides.

In the above-described step S402, an insertion device such as a robot arm may pull out the diabetes sensor 120 inserted into the insertion tube 110 once every predetermined replacement period and replace it with a new diabetes sensor 120. In other words, an insertion device such as a robotic arm can grasp the diabetic sensor 120 inserted into the insertion tube 110 with forceps while looking at the endoscope once a month or once every two months, and then remove the endoscope. By replacing with a new diabetes sensor 120 into the insertion tube 110 installed in the nasolacrimal duct, it is possible to measure the blood sugar easily by continuously performing the diabetic check.

When the diabetic sensor 120 is inserted and installed in the above-mentioned step S402, the thin film-type wireless transmitter 130 having a proximity wireless communication module such as an RF communication module, an NFC communication module, and the like, such as a robotic arm also has a diabetes sensor ( 120 to be fixed to the inner surface or the outer surface of the insertion tube 110 in a connected state (S403).

In the above-described step S403, while checking the hole to enter the sinuses in the nose using an endoscope inserted into the nose, such as a robot arm, the wireless transmitter 130 connected to the diabetes sensor 120 through the hole. It can be installed in the sinuses and can also be simply removed by endoscope through the nose when needed.

When the diabetic sensor 120 is inserted and installed in the above-described step S402, the self-power supply 140, which is an insertion device such as a robotic arm, is a thin film battery, and is also inserted into the diabetic sensor 120 and the wireless transmitter 130 in a state of being connected. It is to be fixed to the inner surface or the outer surface of the tube 110 (S404).

In the above-described step S403, using an endoscope inserted into the nose by an inserting device such as a robot arm, while checking a hole entering the sinus in the nose, the state connected with the diabetes sensor 120 and the wireless transmitter 130 through the hole. Self-power supply 140 can be installed in the sinuses, it can also be simply removed by the endoscope through the nose if necessary.

In one embodiment, when installing the insertion tube 110, the diabetes sensor 120, the wireless transmitter 130, the self-power supply 140 in the above-described step S401 to S404, the wireless transmitter 130 or the self-power supply ( If the volume of the diaphragm 140 is greater than that of the diabetic sensor 120, an insertion device such as a robot arm is inserted into the insertion pipe 110 into the nasolacrimal tube ending in the nose using an endoscope, rather than being inserted into the nasolacrimal tube starting from the eye. The diabetic sensor 120 installed can be pushed up toward the eye, and the wireless transmitter 130 or the self-power supply 140 connected to the other end may be inserted into the sinus.

When the insertion tube 110, the diabetes sensor 120, the wireless transmitter 130, the self-power supply 140 is installed in the above-described step S401 to S404, the self-power supply 140 is electric energy (that is, power) By self-generating the power generated by the corresponding self-converted to each of the components of the diabetes measuring device 100 (that is, diabetes sensor 120, wireless transmitter 130) by converting the converted power to the diabetes sensor 120 ) And the radio transmitter 130 is supplied (S405).

When the power is self-generated and supplied in the above-described step S405, the insertion tube 110 delivers the tears gathered into the nasolacrimal duct to the diabetes sensor 120, wherein the diabetes sensor 120 is supplied from the self-power supply 140. While receiving and driving the power, and receiving the tear transmitted through the insertion tube 110, check the diabetes to measure the blood sugar, and transmits the measured blood sugar to the wireless transmitter (130) (S406).

The wireless transmitter 130 transmits the measured blood sugar transmitted from the diabetes sensor 120 to the outside (for example, the external display device 150) while driving by receiving power supplied from the self-power supply 140. It generates (ie, converts) a wireless signal (ie, a wireless blood sugar information signal) for transmitting the converted wireless blood sugar information signal to the outside (S407).

Meanwhile, the external display device 150 including the wireless receiver 151, the display unit 152, and the power supply unit 153 receives an wireless blood glucose information signal from the wireless transmitter 130 and displays the measured blood sugar as a measurement blood sugar. After a program or a program is installed in advance, the pre-installed app or program is driven. Accordingly, when the wireless receiver 151 having a proximity wireless communication module such as an RF communication module or an NFC communication module receives a wireless blood glucose information signal transmitted from the wireless transmitter 130 (S408), the received wireless The blood sugar information signal is converted into the measured blood sugar to transfer the converted measured blood sugar to the display unit 152 (S409).

The display unit 152 having screen display means such as an LCD displays the measured blood sugar transmitted from the wireless receiver 151 on the screen (S410).

As described above, the embodiment of the present invention is not implemented only through the above-described apparatus and / or method, but through a program for realizing a function corresponding to the configuration of the embodiment of the present invention, a recording medium on which the program is recorded, and the like. Such an implementation may be easily implemented by those skilled in the art to which the present disclosure pertains based on the description of the above-described embodiments.

Although the embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements of those skilled in the art using the basic concepts of the present invention defined in the following claims are also provided. It belongs to the scope of rights.

Claims

An insertion tube installed in the nasolacrimal duct to deliver tears collected into the nasolacrimal duct;

A diabetic sensor inserted into the insertion tube to check a diabetes by receiving tears delivered through the insertion tube and measuring blood glucose;

A wireless transmitter for generating and transmitting a blood glucose information signal for transmitting blood glucose measured by the diabetes sensor to the outside; And

Diabetes measuring device comprising a self-power supply for converting and supplying power to the diabetes sensor and the wireless transmitter.
The method of claim 1, wherein the diabetes sensor,

A cylindrical shape is formed along a cylindrical inner surface of the insertion tube so that tears pass through the inner surface of the insertion tube, or inside the insertion tube. Diabetes measuring device characterized in that the tears pass on both sides by putting the date in the form.
The wireless transmitter of claim 1,

Diabetic measuring device is connected to the diabetes sensor in the form of a thin film is fixed to the inner surface or the outer surface or the sinus of the insertion tube.
According to claim 1, wherein the self-power supply,

Diabetic measuring device is connected to the diabetes sensor and the wireless transmitter, characterized in that the battery of the thin film form fixed to the inner surface or the outer surface or the sinus of the insertion tube.
The method of claim 1,

And an external display device for receiving the wireless blood glucose information signal from the wireless transmitter and displaying the measured blood sugar.
The method of claim 5, wherein the external display device,

A wireless receiver which receives the wireless blood glucose information signal transmitted from the wireless transmitter and converts the measured blood glucose into measured blood glucose;

A display unit which displays the measured blood sugar converted by the wireless receiver on a screen; And

Diabetes measuring device characterized in that it is provided with a power supply for converting the power supplied to the wireless receiving unit and the display unit to receive the external commercial power or the power of the battery or rechargeable battery.
Delivering tears collected into the nasolacrimal duct by the insertion tube inserted into the nasolacrimal duct;

A self-power supply converts and supplies power to a diabetes sensor and a wireless transmitter;

A diabetic sensor inserted into the insertion tube to receive the tear and check diabetes to measure blood glucose; And

And a wireless transmitter generating and transmitting a blood glucose information signal for transmitting blood glucose measured by the diabetes sensor to the outside.
The method of claim 7, wherein

Inserting and inserting an insertion tube, which is a tube made of silicon, into the nasolacrimal duct using an insertion device by using a probe or an endoscope;

Inserting, by the insertion apparatus, the diabetes sensor into the insertion tube using an endoscope;

When the diabetic sensor is inserted and installed, the inserting device using an endoscope to securely install a wireless transmitter connected to the diabetic sensor to an inner surface, an outer surface, or a sinus of the insertion tube; And

When the diabetic sensor is inserted and installed, the inserting device uses an endoscope to fix the self-power supply in a state connected to the diabetic sensor and the wireless transmitter to the inner surface or the outer surface or the sinus of the insertion tube. Operation method of the diabetic measuring device comprising a.
The method of claim 8, wherein the diabetic sensor is inserted and installed,

The insertion device is installed along the cylindrical inner surface of the insertion tube in a cylindrical shape so that tears pass through the inner surface, or inside the insertion tube. Operating method of the diabetic measuring device, characterized in that installed in the form of a date so that tears pass on both sides.
The method of claim 8, wherein the diabetic sensor is inserted and installed,

The inserting device is characterized in that it further comprises the step of pulling out the diabetic sensor inserted into the insertion tube with a forceps while looking through the endoscope every preset replacement period, and replacing the new diabetic sensor into the insertion tube using the endoscope. Operation method of diabetic measuring apparatus to say.